The American Academy of Dermatology recently updated their guidelines regarding the treatment of moderate-to-severe atopic dermatitis to expand the recommended use of systemic therapies like biologics and JAK inhibitors. To help ensure our approach is up to date, Dr. Jennifer Caudle speaks with Dr. Steven Feldman about the new guidelines and how we can implement them into clinical practice. Dr. Feldman is a Professor of Dermatology, Pathology, Social Sciences and Health Policy at the Wake Forest University School of Medicine in Winston-Salem, North Carolina.